METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer

Abbreviations ASCVD: Atherosclerotic cardiovascular disease BMI: Body mass index CCI: Charlsons Comorbidity Index CGRD: Chang Gung Research Database CI: Confidence interval CKD: Chronic kidney disease DKA: Diabetic ketoacidosis DKD: Diabetic kidney disease DM: Diabetes mellitus DPP-4is: Dipeptidyl peptidase 4 inhibitors DSCP: Diabetic Shared Care Program eGFR: Estimated glomerular filtration rate EMR: Electronic medical record ESKD: End-stage kidney disease GLP-1RAs: Glucagon-like peptide 1 receptor agonists HbA1c: Glycated hemoglobin HHS: Hyperosmolar hyperglycemic state HR: Hazard ratio ICAM-1: Intercellular adhesion molecules 1 MACEs: Major adverse cardiovascular events MDRD: Modification of diet in renal disease MI: Myocardial infarction NHE3: Sodiumhydrogen exchanger 3 SGLT2is: Sodiumglucose cotransporter 2 inhibitors SHR: Subdistribution hazard ratio STD: Standardized difference TNF: Tumor necrosis factor alpha UACR: Urine albumin-to-creatinine ratio VCAM-1: Vascular cell adhesion protein 1 References Almourani R, Chinnakotla B, Patel R, et al

Recomposition Without Androgenic Risk Unlike anabolic steroids, IGF-1 LR3 is non-androgenic, meaning it wont cause masculinizing side effects like voice deepening or facial hair
Kudla J, Becker D, Grill E, Hedrich R, Hippler M, Kummer U, et al
Melanotan II is a synthetic, non-selective analogue of -melanocyte-stimulating hormone (-MSH), developed for advanced preclinical research across multiple melanocortin pathways
(15 November 2013)